OPTICAL CONFIGURATION METHODS FOR SPECTRAL SCATTER FLOW CYTOMETRY Read more about OPTICAL CONFIGURATION METHODS FOR SPECTRAL SCATTER FLOW CYTOMETRY France18808559.1Filed on 2018-10-23
OPTICAL CONFIGURATION METHODS FOR SPECTRAL SCATTER FLOW CYTOMETRY Read more about OPTICAL CONFIGURATION METHODS FOR SPECTRAL SCATTER FLOW CYTOMETRY Germany18808559.1Filed on 2018-10-23
BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE Read more about BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE US Patent 12,012,438Filed on 2021-06-14
Chimeric Antigen Receptors Targeting CD-19 Read more about Chimeric Antigen Receptors Targeting CD-19 MexicoMX/a/2021/006239Filed on 2021-05-27
HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation Read more about HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation Patent Cooperation TreatyPCT/US2021/041737Filed on 2021-07-15
HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation Read more about HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation Patent Cooperation TreatyPCT/US2021/041375Filed on 2021-07-13
Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation Read more about Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation European Patent22166152.3Filed on 2022-03-31
USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS Read more about USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS Patent Cooperation TreatyPCT/US2021/021831Filed on 2021-03-11
High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins Read more about High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins European Patent21185510.1Filed on 2021-07-14
IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF Read more about IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF European Patent19865927.8Filed on 2019-09-30